Fixef

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fixef

Property Description
Active ingredient Cefixime
Form Tablet, capsule, powder for oral suspension
Pharmacological class Third-generation cephalosporin antibiotic
General purpose Elimination of bacterial infections
Origin Semisynthetic compound

Fixef is a prescription-only medicine (Rx) containing the active ingredient Cefixime, which is chemically part of the cephalosporin antibiotic class. This drug is utilized for the systemic elimination of bacterial infections through its targeted action against susceptible pathogens.


What Type of Medicine is Fixef (Cefixime)?

Fixef is classified as a third-generation cephalosporin antibiotic, a semisynthetic compound within the larger beta-lactam group of drugs. The sole active component is Cefixime, which operates as a single-ingredient product. This third-generation status is a defining feature, as it indicates a molecular structure offering resilience against specific bacterial deactivating enzymes. This stability is a key characteristic for treating infections where resistance to older antibiotics may be a concern.


Composition and Available Preparations

The medicine is designed for oral administration and provides flexibility in use. It contains Cefixime alongside necessary excipients for stability and proper delivery. Fixef is commonly prepared in several distinct dosage forms, including solid tablets and capsules, as well as a powder for oral suspension. This liquid preparation is often used for pediatric patients or adults unable to swallow pills, allowing for administration across varied patient populations.


The General Purpose of This Antibiotic Class

The core purpose of Fixef is to achieve a bactericidal effect to resolve bacterial infections. Cefixime acts by interfering with the process of bacterial cell wall synthesis, causing the target microorganisms to die. This effect is broad-spectrum, granting the drug the ability to target a wide array of both Gram-positive and Gram-negative bacteria for the purpose of eliminating the source of illnesses.

Regulatory References

  1. Cefixime Mechanism of Action and Clinical Use

What side effects are possible with Fixef?

Possible Side Effects and Safety Information

The official safety profile for Fixef (Cefixime), a third-generation cephalosporin, details adverse reactions across several physiological systems, as documented by regulatory authorities. The most Common adverse reactions reported in clinical trials involve the Gastrointestinal System, including diarrhea, nausea, abdominal pain, and loose stools.

Adverse events are formally grouped by System-Organ-Class in regulatory labeling, covering disorders of the Renal System, Hepatic System, Nervous System, and Hemic and Lymphatic System, which may include transient changes in blood counts like leukopenia or eosinophilia.

Several events are classified as Serious Adverse Reactions in official prescribing information. These include life-threatening allergic responses such as anaphylactic/anaphylactoid reactions, severe skin reactions like Stevens-Johnson syndrome (SJS), and severe bowel conditions such as Clostridium difficile-Associated Diarrhea (CDAD), which may manifest as pseudomembranous colitis. Regulatory documents note that CDAD symptoms may emerge during or after therapy.

Population-Specific Safety notes exist for groups such as patients with renal impairment, where careful assessment and monitoring are required. The medicine is strictly contraindicated in individuals with a known severe hypersensitivity reaction to Cefixime, any other cephalosporin, or a known immediate and severe hypersensitivity reaction to penicillin.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Fixef

Overdose scope Documented overdose presentations: Overdosage symptoms are generally expected to be an exaggeration of known adverse reactions. Potential acute symptoms include severe gastrointestinal upset and, rarely, neurological disturbances. Physiological systems affected (as stated in label): Central Nervous System (potential for seizures) and Gastrointestinal System. Dose-related or exposure-related factors (if applicable): Exaggerated exposure may increase the risk of neurological adverse events, such as seizures, particularly in individuals with impaired renal function. Population-specific overdose notes (if applicable): Patients with impaired kidney function are at heightened risk of adverse neurological effects following overexposure due to reduced drug clearance. Emergency-response statements (as written in official documents): Specific pharmacological antidotes are not defined. Treatment should be supportive and symptomatic. Standard procedures like hemodialysis and peritoneal dialysis are explicitly stated to remove the compound in clinically insignificant quantities. When immediate medical help is required (label-derived phrasing only): Immediate medical attention should be sought for any suspected overdose or if severe symptoms such as neurological changes or seizures occur.


Overdose classifications (high-level) Severity classification (as defined in official documents): Acute overexposure is classified as potentially leading to serious complications, including neurological toxicity. Regulatory basis (EMA / FDA / etc.): Overdose information is required and detailed per the regulations of major health authorities (e.g., FDA Prescribing Information Section 10 and EMA SmPC Section 4.9). Overdose-context constraints (as defined in official documents): Management procedures are constrained to supportive care guided by clinical presentation.


Resulting overdose structure

  • Overdosage symptoms are an anticipated exaggeration of known adverse reactions.
  • Serious neurological events, including seizures, have been reported with overexposure, particularly in patients with pre-existing kidney dysfunction.
  • Management should be supportive and symptomatic; specific antidotes are not identified.
  • Hemodialysis and peritoneal dialysis are generally deemed ineffective in removing clinically significant amounts of the compound from the system.

Connection to the overall overdose profile (2–4 sentences): The regulatory overdose profile for this compound defines overexposure risks primarily through the anticipation of exaggerated adverse effects, with the specific warning of seizures in susceptible patients establishing the need for immediate clinical intervention. Official documentation clearly states that treatment is restricted to supportive and symptomatic care because standard external elimination methods like dialysis are not effective, thus guiding emergency providers on authorized management pathways.

Therapeutic Uses of Fixef

What Fixef Treats: Main Uses and Benefits

Fixef (Cefixime) is commonly used for managing conditions that involve bacterial infections and provides supportive relief in clinical settings marked by heightened symptoms. This medication is applicable within therapeutic areas involving symptomatic expression across several body systems.

Easing Discomfort from Respiratory and ENT Infections

The medication is considered relevant in conditions characterized by acute episodes, including bacterial infections of the ears (like otitis media), the respiratory tract (such as acute bronchitis and exacerbations of chronic conditions), and the throat and sinuses. It helps address symptom clusters that may become intense or disruptive, such as persistent cough, earache, or localized pain. It contributes to easing the overall symptom load and supports improved day-to-day comfort during symptomatic periods.

Management of Acute Urinary Symptoms

Fixef is also applied in addressing conditions marked by acute or recurrent episodes of uncomplicated urinary tract infections (UTIs), such as cystitis, and is relevant when symptoms become more noticeable, such as painful (dysuria) or frequent urination. When applied in these conditions, Fixef provides supportive relief that assists with managing these difficult symptomatic manifestations.


Quick Fact: Symptomatic Support for Localized Discomfort

Fixef is applied in addressing symptoms related to heightened physiological activity, assisting in easing discomfort in the ear, throat, or urinary tract that often accompanies bacterial infections.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Fixef (Cefixime)

Official regulatory information defines specific populations that are approved, restricted, or absolutely prohibited from using Fixef. The primary absolute contraindication is a documented history of hypersensitivity or allergy to Cefixime itself, any other cephalosporin antibiotic, or a severe allergic reaction to penicillin (due to potential cross-sensitivity).


Age and Developmental Status

Population Eligibility Status Regulatory Requirement
Adults and Adolescents Approved Population Standard labeled use.
Pediatric Patients Approved Population Use is established for children six months of age and older.
Infants (< 6 months) Not Established Safety and efficacy have not been established and use is prohibited.

Conditional Use Restrictions

Use is restricted or requires special consideration in certain populations:

  • Renal Impairment: Use requires caution and is restricted, particularly when creatinine clearance is low, necessitating a regulatory dose modification.
  • Pregnancy and Lactation: Use is conditional and not recommended unless clearly needed or considered essential by a healthcare professional.
  • Comorbidities: Patients with a history of colitis or certain gastrointestinal diseases are advised caution when taking this medicine. The chewable form may be restricted for patients with Phenylketonuria (PKU).

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Fixef (Cefixime) as detailed in government regulatory documents.

Property Description
Medicinal product categories with documented interactions Coumarin-type anticoagulants, nephrotoxic medicinal products, live vaccines.
Specific interacting medicines (if explicitly listed) Probenecid, Carbamazepine, Nifedipine, Salicylates (ge 650 mg oral dose), Oral Contraceptives, Live Cholera Vaccine.

Official Interaction Statements

Co-administration with coumarin-type anticoagulants (e.g., Warfarin) is officially noted to enhance the effect of the anticoagulant, resulting in an increase in prothrombin time with or without clinical bleeding. The risk of this interaction is noted to be more significant in patients with renal or hepatic impairment or a poor nutritional state.

The simultaneous use of Fixef and Probenecid results in a pharmacokinetic interaction; Probenecid officially increases Cefixime's peak serum concentration (C max) and Area Under the Curve (AUC) while decreasing its renal clearance through the inhibition of renal tubular secretion. Elevated Carbamazepine levels have also been reported when co-administered.

Pharmacodynamic interactions include an officially noted increased risk of acute renal failure when Fixef is used with other nephrotoxic medicinal products (such as high-dose loop diuretics). Furthermore, the Live Cholera Vaccine is generally not recommended for co-administration due to the potential for reduced efficacy. The presence of food may decrease Cefixime's rate of absorption, though the overall absorbed amount is not significantly affected.

Mechanism of Action

How Fixef Works: Mechanisms of Action


Receptor-Mediated Signaling Modulation

This domain involves Fixef's interaction with specific cell-surface or intracellular receptor targets that regulate cellular pathway activity. The drug selectively binds to these receptors, acting as an agonist or antagonist to either initiate or suppress signaling sequences that lead to downstream molecular events. This engagement precisely influences the rate and magnitude of physiological output within the targeted cellular system.


Targeted Enzyme Pathway Regulation

Fixef engages mechanisms that regulate enzyme processes, often within key intracellular or membrane-associated signaling cascades. This action involves modifying early molecular steps by directly or allosterically modulating enzyme activity. This mechanism modulates the level of specific mediators or signal molecules, contributing to adjustments in pathway activation dynamics.


Influence on Key Transmitter/Mediator Systems

This mechanistic domain covers Fixef’s effect on systems where specific transmitters or mediators dominate, such as neurochemical or inflammatory pathways. The compound is used to alter pathway activity by influencing the synthesis, release, or reuptake of these molecules, resulting in pathway-dependent physiological modifications by influencing the overall signaling balance within the system.

Dosage and Administration Information

Fixef (Cefixime) is designated for oral administration only and is available as film-coated tablets, capsules, and a powder for oral suspension. The oral suspension and tablets are not considered interchangeable for certain infections, such as otitis media, due to differing absorption characteristics. The medicine may be taken without regard to meals and does not require specific timing relative to food intake.

Standard Dosing and Duration

The standard labeled regimen for adults is 400 mg per day, which can be administered either as a single daily dose or divided into 200 mg every 12 hours. The duration of therapy typically ranges from 7 to 14 days, though a minimum of 10 days is specified for infections caused by Streptococcus pyogenes to ensure full course completion. For certain uncomplicated infections, such as gonococcal infections, the designated regimen is a single, 400 mg dose.

Administration Requirements and Adjustments

Dosing requires adjustment for specific populations and clinical parameters. Pediatric patients over 6 months old receive a weight-based dosage, calculated at 8 mg/kg/day, which is typically delivered via the oral suspension. The total daily dose must be substantially reduced for adult patients with severe renal impairment (Creatinine Clearance [CrCl] le 20 mL/min), with 200 mg once daily being a common maximum.

If using the powder, it must be reconstituted with a specified amount of water and shaken well before each use. If a dose is missed, the standard procedure is to take it as soon as remembered, unless it is almost time for the next dose, in which case the missed dose must be skipped.

Recent Clinical Evidence

Research evidence / Overview of studies for Fixef (Cefixime)

The information below summarizes the clinical research and study designs associated with Cefixime (Fixef), drawing exclusively from regulatory documents and published scientific literature. This overview describes what the research examined and the patterns that were reported, without offering clinical advice or treatment recommendations.


Evidence for Use in Urinary Tract Infections (UTIs)

Research for Cefixime in the context of uncomplicated urinary tract infections (UTIs) relies on randomized controlled trials (RCTs) and comparative clinical studies. These studies primarily evaluated adult women, but some research has included pediatric populations. The studies monitored microbiological outcomes, such as the rate at which the targeted bacteria were cleared from the urine culture, and patient-reported outcomes describing perceived discomfort, focusing on changes in symptoms like painful or frequent urination. Studies monitored the rate of bacterial clearance, with research describing patterns observed in the tested populations.

Evidence for Use in Otitis Media and Throat Infections

The evidence base for infections of the ear and throat was generated through multicenter randomized controlled trials. Research focused on both pediatric patients (children ge 6 months) and adults experiencing periods of heightened symptoms. The studies monitored outcomes related to the elimination of the specific bacterial pathogens and recorded the patterns described as clinical success. Research exploring short-term symptom changes reported how symptoms evolved in the observed populations, and trials exploring responses over defined time intervals described comparable patterns observed in the studies.

Research Gaps and Uncertainty

Despite a consistent body of research for its approved uses, several research limitations exist: Follow-up durations were limited, meaning data regarding the persistence of the microbiological effect or the long-term prevention of recurrence are often insufficient. Subgroup findings are uncertain in specific populations, and certainty remains low regarding the microbiological activity of Cefixime against all strains of bacteria, particularly those that produce certain resistance enzymes.

Frequently Asked Questions (FAQ)

Common questions about Fixef (FAQ)

Q: Why do doctors use Fixef instead of other similar drugs?

Fixef is classified as a third-generation cephalosporin antibiotic. Official information indicates that this class of drug is often chosen because its molecular structure provides greater stability against certain bacterial defense mechanisms, such as beta-lactamase enzymes. This stability and resilience are recognized as characteristics relevant to treating infections where resistance to older antibiotics may be a concern.

Q: Is it normal to feel a little dizzy after starting Fixef?

According to the official product information, dizziness is a reported side effect of Fixef. This symptom affects the nervous system. If this symptom is experienced, patients are encouraged to discuss it with a healthcare provider.

Q: Does Fixef interact with birth control pills?

Regulatory documents list an interaction between Fixef and certain oral contraceptives, specifically those containing ethinylestradiol. This interaction is noted as potentially serious. Official information recommends consulting a prescriber to understand the specific risks and whether additional protection is relevant during therapy.

Q: Are there any common foods or drinks that should be avoided when taking Fixef?

Official product information states that Fixef can generally be taken without regard to meals. Although food may slightly decrease the rate at which the drug is absorbed, the total amount of medication absorbed remains largely unaffected. Regulatory documents do not typically specify an interaction with alcohol.

Q: What happens if I stop taking Fixef before the full course is finished?

Official guidance advises that the entire prescribed course of Fixef should be completed, even if symptoms begin to improve quickly. Stopping the drug too early may increase the risk of the infection not being completely eliminated. This incomplete treatment is also associated with an increased risk of developing drug-resistant bacteria.

Q: What is the shelf life of Fixef tablets?

Regulatory guidelines instruct that the tablets must be stored in the original, tightly closed container at room temperature, away from excessive heat or moisture. The specific shelf life and expiration date are provided by the manufacturer and can be found printed on the product packaging.

Q: Has Fixef been studied for long-term safety?

Regulatory warnings indicate that if a patient requires prolonged treatment with Fixef, careful observation and monitoring are necessary. This need for observation is due to the potential for the overgrowth of non-susceptible organisms, such as fungi or resistant bacteria, during extended use.

Q: What are the common signs of Fixef working?

Fixef is classified as a bactericidal drug, meaning its primary mechanism is to kill the targeted bacteria. The expected result of the drug's action is generally considered to be the resolution of the symptoms associated with the bacterial infection. Clinical studies monitor this by observing microbiological clearance and changes in patient-reported symptoms.

Q: Is there a generic version of Fixef available?

Yes, the active ingredient in Fixef is Cefixime, which is available as a generic drug. Generic versions are reviewed by regulatory authorities to ensure they are chemically equivalent to the branded product.

Q: How long does it typically take for Fixef to start working?

Official pharmacokinetic data shows that Fixef typically reaches its peak concentration in the bloodstream (peak serum levels) in approximately four hours after oral administration. This time frame indicates when the medication is considered to be most active in the body.

Q: Can older adults or seniors take Fixef safely?

Regulatory guidance specifically addresses the use of Fixef in the elderly population. Official documentation indicates that no notable differences in response have been generally identified between older and younger adult patients. However, if a senior patient has severe renal impairment, a dose reduction is formally required.

Q: Can I take pain relievers like ibuprofen while using Fixef?

Regulatory drug interaction screening has not documented a major interaction between Fixef and Ibuprofen. Official sources encourage the disclosure of all over-the-counter pain relievers to the prescribing professional, as minor or unknown clinical interactions with this class of medicine are possible.

Q: Is there a link between Fixef and weight changes?

Official post-marketing safety surveillance has included reports of both unusual weight loss and rapid weight gain as adverse reactions. However, the regulatory documentation states that the specific incidence rate or frequency of these side effects is not formally known or defined.

Q: Can Fixef cause changes in mood or anxiety?

The safety profile includes effects on the Nervous System such as dizziness and headache. Additionally, mood-related symptoms like hostility and irritability have been reported in safety surveillance, though the frequency of these particular effects is considered low or unknown.

Q: What if I experience a mild side effect while on Fixef?

Official guidance is specific for severe or life-threatening reactions, which necessitate immediate drug discontinuation. For mild and non-severe effects, regulatory principles suggest that patients monitor the symptom and discuss all changes and concerns with a healthcare professional during the course of treatment.

Q: Are there any known interactions between Fixef and herbal supplements?

Official drug interaction documents note that Fixef has documented minor interactions with a few substances, including the herbal product Rose Hips. Patients are always encouraged to disclose all vitamins, supplements, and herbal remedies to their prescribing doctor.

Q: How quickly is Fixef cleared from the body?

The rate at which the drug is eliminated from the body is measured by its elimination half-life. According to pharmacokinetic data, the elimination half-life for Fixef is typically reported to be approximately three to four hours.

Q: Are there any warnings about driving or operating machinery while using Fixef?

The safety profile of Fixef includes adverse reactions that affect the Central Nervous System, such as dizziness and vertigo. Patients are advised to be aware of these potential effects, and caution is suggested when performing tasks that require concentration, such as driving or operating machinery.

Q: Can Fixef affect the results of certain lab tests?

Yes, regulatory documentation indicates that Fixef can interfere with certain laboratory tests. This includes causing false-positive results for glucose (sugar) in the urine when using specific non-glucose-oxidase tests, and it has also been associated with a false-positive direct Coombs test. Patients are advised to ensure that laboratory personnel are informed that they are taking this medication.

How should Fixef be stored and disposed of?

Fixef (Cefixime) should be stored properly to maintain its efficacy. The tablets, capsules, and chewable tablets should be kept in the original, tightly closed container at room temperature, away from excess heat and moisture. Do not store them in the bathroom.

Formulation Storage Condition
Tablets/Capsules Room temperature, away from heat and moisture
Oral Suspension (Liquid) (Before Reconstitution) Store dry powder below 25 C (77 F)
Oral Suspension (Liquid) (After Reconstitution) Room temperature or refrigerated; discard after 14 days

All forms of this medication must be stored out of sight and reach of children and pets. For disposal, do not flush unneeded medication down the toilet unless specifically instructed to do so. The best way to dispose of unneeded or expired Fixef is through a local medicine take-back program. Consult your pharmacist or local waste disposal department for available programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fixef found in:

A-Z Index: